about
Ability of Measures of Adiposity in Identifying Adverse Levels of Inflammatory and Metabolic Markers in Adolescents.Muscular fitness, Southern European Atlantic Diet and inflammation in adolescents. Azorean Physical Activity and Health Study II.Ability of Nontraditional Risk Factors and Inflammatory Biomarkers for Cardiovascular Disease to Identify High Cardiometabolic Risk in Adolescents: Results From the LabMed Physical Activity Study.Low-grade inflammation and muscular fitness on insulin resistance in adolescents: Results from LabMed Physical Activity Study.Cardiorespiratory Fitness and Blood Pressure: A Longitudinal Analysis.Cardiorespiratory fitness and inflammatory profile on cardiometabolic risk in adolescents from the LabMed Physical Activity Study.Muscular fitness and metabolic and inflammatory biomarkers in adolescents: Results from LabMed Physical Activity Study.Associations between health-related quality of life and body mass index in Portuguese adolescents: LabMed physical activity study.Association between serum adiponectin levels and muscular fitness in Portuguese adolescents: LabMed Physical Activity Study.Serum Adiponectin Levels and Cardiorespiratory Fitness in Nonoverweight and Overweight Portuguese Adolescents: The LabMed Physical Activity Study.Association between Leptin, Adiponectin, and Leptin/Adiponectin Ratio with Clustered Metabolic Risk Factors in Portuguese Adolescents: The LabMed Physical Activity Study.Longitudinal associations between motor competence and different physical activity intensities: LabMed physical activity studyAssociations between physical fitness and adherence to the Mediterranean diet with health-related quality of life in adolescents: results from the LabMed Physical Activity StudyEnvironmental perceptions and its associations with physical fitness and body composition in adolescents: longitudinal results from the LabMed Physical Activity StudyAssociation of Dairy Product Consumption with Metabolic and Inflammatory Biomarkers in Adolescents: A Cross-Sectional Analysis from the LabMed Study
P50
Q40942585-CCC0D064-6967-435D-8C50-B105D8BFD822Q47228170-67C820D7-4E70-4EC8-ADE4-1D44670F9468Q47305236-93CFAA85-2A75-487E-8ACC-E4F0DAF33E1CQ47368754-88FA92EB-3E79-46E2-93BA-7B54D1128DFDQ47574229-9B6AEC10-B092-48E2-B9C0-C6EE48A5E9B3Q47699735-02E7AF1F-85E7-45C1-8AB7-29181D6AEB91Q48200015-BE7BE023-3B9D-4BBA-9F8E-B9766836DA55Q50063611-D40CEFBF-CDF9-4511-BD86-74EAEA782CC9Q50220649-FEE2BA03-BCE1-4B0C-81E9-A6D4596FA5A0Q51276415-A4D9170E-621D-49DB-99B3-EE2AF8AF310AQ53723477-C33EBB11-ABD1-4BD3-A13B-034F03A14030Q61439590-1563996A-5E6A-4174-8169-3C035591EDADQ88201611-896505A8-51FB-46BB-A927-A69108A75823Q88317099-0B36DD23-DB5C-426F-9F74-62576A72A969Q90223900-A261685D-D04E-44AB-80BC-1D8A1EFBF7FF
P50
description
researcher
@en
wetenschapper
@nl
name
José Oliveira-Santos
@en
José Oliveira-Santos
@nl
type
label
José Oliveira-Santos
@en
José Oliveira-Santos
@nl
prefLabel
José Oliveira-Santos
@en
José Oliveira-Santos
@nl
P31
P496
0000-0003-2739-6183